SNDX Free Cash Flow Growth
Syndax Pharmaceuticals Inc · Free Cash Flow Growth
SNDX Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported27.03%period ending
SNDX TTM Free Cash Flow YoY % (-201.31% → 27.03%)
Year-over-year change
High-resolution chart · PNG
SNDX free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 27.0264% | |
| 2.8504% | |
| -17.5567% | |
| -20.1446% | |
| -25.4864% | |
| -39.8183% | |
| -71.1714% | |
| -82.1114% | |
| -91.3684% | |
| -56.4617% | |
| -20.1429% | |
| -1,293.4516% | |
| -1,809.3622% | |
| -1,455.8178% | |
| -560.9165% | |
| 88.3028% | |
| 91.8063% | |
| 112.3967% | |
| 140.6988% | |
| -27.5806% | |
| -37.506% | |
| -56.7698% | |
| -40.7966% | |
| -29.1149% | |
| 6.8287% | |
| 24.1199% | |
| 26.3483% | |
| 20.2981% | |
| -8.0837% | |
| -19.4711% | |
| -44.8067% | |
| -47.261% | |
| -25.4209% | |
| -31.9615% | |
| -33.9855% | |
| -53.8018% | |
| -101.5074% | |
| -107.1493% | |
| -1,329.8748% | |
| -1,699.2638% | |
| -2,490.4465% | |
| -1,829.1379% | |
| 82.795% | |
| 88.1057% | |
| 107.2751% | |
| 111.1969% | |
| -96.3317% | |
| -201.315% |